![]()
|
|
||||||||
J. Biol. Chem., Vol. 256, Issue 22, 11447-11451, Nov, 1981
D Derse, YC Cheng, PA Furman, MH St. Clair and GB Elion
The inhibition of highly purified herpes simplex virus (HSV)-induced and
host cell DNA polymerases by the triphosphate form of 9-(2-
hydroxyethoxymethyl)guanine (acyclovir; acycloguanosine) was examined.
Acyclovir triphosphate (acyclo-GTP) competitively inhibited the
incorporation of dGMP into DNA, catalyzed by HSV DNA polymerase; apparent
Km and Ki values of dGTP and acyclo-GTP were 0.15 microM and 0.003 microM,
respectively. HeLa DNA polymerase alpha was also competitively inhibited;
Km and Ki values of dGTP and acyclo-GTP were 1.2 microM and 0.18 microM,
respectively. In contrast, HeLa DNA polymerase beta was insensitive to the
analogue. The "limited" DNA synthesis observed when dGTP was omitted from
HSV or alpha DNA polymerase reactions was inhibited by acyclo-GTP in a
concentration- dependent manner. Prior incubation of activated DNA,
acyclo-GTP, and DNA polymerase (alpha or HSV resulted in a marked decrease
in the utilization of the primer-template in subsequent DNA polymerase
reactions. This decreased ability of preincubated primer-templates to
support DNA synthesis was dependent on acyclo-GTP, enzyme concentration,
and the time of prior incubation. Acyclo-GMP-terminated DNA was found to
inhibit HSV DNA polymerase-catalyzed DNA synthesis. Kinetic experiments
with variable concentrations of activated DNA and fixed concentrations of
acyclo-GMP-terminated DNA revealed a noncompetitive inhibition of HSV-1 DNA
polymerase. The apparent Km of 3'-hydroxyl termini was 1.1 X 10(-7) M, the
Kii and Kis of acyclo-GMP termini in activated DNA were 8.8 X 10(-8) M and
2.1 X 10(-9) M, respectively. Finally, 14C-labeled acyclo-GMP residues
incorporated into activated DNA by HSV-1 DNA polymerase could not be
excised by the polymerase-associated 3',5'-exonuclease activity.
Inhibition of purified human and herpes simplex virus-induced DNA polymerases by 9-(2-hydroxyethoxymethyl)guanine triphosphate. Effects on primer-template function
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
J. W. Hanes, Y. Zhu, D. S. Parris, and K. A. Johnson Enzymatic Therapeutic Index of Acyclovir: VIRAL VERSUS HUMAN POLYMERASE {gamma} SPECIFICITY J. Biol. Chem., August 24, 2007; 282(34): 25159 - 25167. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Suzutani, K. Ishioka, E. De Clercq, K. Ishibashi, H. Kaneko, T. Kira, K.-i. Hashimoto, M. Ogasawara, K. Ohtani, N. Wakamiya, et al. Differential Mutation Patterns in Thymidine Kinase and DNA Polymerase Genes of Herpes Simplex Virus Type 1 Clones Passaged in the Presence of Acyclovir or Penciclovir Antimicrob. Agents Chemother., May 1, 2003; 47(5): 1707 - 1713. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. J. Leary, R. Wittrock, R. T. Sarisky, A. Weinberg, and M. J. Levin Susceptibilities of Herpes Simplex Viruses to Penciclovir and Acyclovir in Eight Cell Lines Antimicrob. Agents Chemother., March 1, 2002; 46(3): 762 - 768. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Reefschlaeger, W. Bender, S. Hallenberger, O. Weber, P. Eckenberg, S. Goldmann, M. Haerter, I. Buerger, J. Trappe, J. A. Herrington, et al. Novel non-nucleoside inhibitors of cytomegaloviruses (BAY 38-4766): in vitro and in vivo antiviral activity and mechanism of action J. Antimicrob. Chemother., December 1, 2001; 48(6): 757 - 767. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Y. Hostetler, J. R. Beadle, W. E. Hornbuckle, C. A. Bellezza, I. A. Tochkov, P. J. Cote, J. L. Gerin, B. E. Korba, and B. C. Tennant Antiviral Activities of Oral 1-O-Hexadecylpropanediol-3-Phosphoacyclovir and Acyclovir in Woodchucks with Chronic Woodchuck Hepatitis Virus Infection Antimicrob. Agents Chemother., July 1, 2000; 44(7): 1964 - 1969. [Abstract] [Full Text] |
||||
![]() |
H. H. Balfour Antiviral Drugs N. Engl. J. Med., April 22, 1999; 340(16): 1255 - 1268. [Full Text] [PDF] |
||||
![]() |
R. O. Baker and J. D. Hall Impaired Mismatch Extension by a Herpes Simplex DNA Polymerase Mutant with an Editing Nuclease Defect J. Biol. Chem., September 11, 1998; 273(37): 24075 - 24082. [Abstract] [Full Text] [PDF] |
||||
![]() |
R Dolin Antiviral chemotherapy and chemoprophylaxis Science, March 15, 1985; 227(4692): 1296 - 1303. [Abstract] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |